Evaluation of Maxillary Anterior Teeth Width and Their Relation to the Calculated Values for Smile Designing.

AIM AND OBJECTIVE: The present study was conducted to determine the golden proportion, golden mean, and the Preston proportion of the individuals between the widths of six maxillary anterior teeth and to determine which proportional formula exists in the population. MATERIALS AND METHODS: This study was conducted among 60 participants between 18 years and 30 years of age with an esthetic smile. They were grouped into 30 females and 30 males. Maxillary arch impressions were made using irreversible hydrocolloid material from each individual. The width of the anterior teeth on the graph paper was analyzed by using digital vernier caliper. The data were statistically analyzed by one way ANOVA test. RESULTS: The study revealed that the formula of golden proportion and golden mean had no statistical differences between males and females but the Preston proportion has shown statistical differences in the total population. CONCLUSION: From the current study, it was concluded that the formulas of golden mean and golden proportion proposed by Ward can be used for smile designing and full mouth rehabilitations. CLINICAL SIGNIFICANCE: Demand for smiles has gained its importance with time. The golden proportion, golden mean, and the Preston proportion are the guidelines used by the professional for better esthetic proportion in the dentition.

Fouling resistant functional blend membrane for removal of organic matter and heavy metal ions.

This study investigates the removal of heavy metal ions and humic acid using Cellulose acetate (CA) and Poly (methyl vinyl ether-alt-maleic acid) (PMVEMA) blend membranes. Antifouling properties of blend membranes were also investigated. Flat sheet membranes were prepared by phase inversion technique using different concentrations of CA and PMVEMA. The prepared membranes were characterized and their performance was evaluated by measuring pure water flux, water uptake capacity and humic acid removal. Rejection of humic acid (HA) was observed to be around 97% for all the blend membranes because of electrostatic interactions between the functional groups of HA and blends. The fouling characteristics of the membranes was assessed using HA as a foulant and the antifouling capacity of blend membranes was observed to be greater with a flux recovery ratio of almost 95% when compared to bare CA, commercial CA (TechInc) and other reported CA blends used for HA rejection. Also, the blend membranes were very effective in removing heavy metal ions (Pb2+, Cd2+ and Cr+6) and humic acid simultaneously. Overall, the PMVEMA modified CA membranes can open up new possibilities in enhancing the hydrophilicity, permeability and antifouling properties.

Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells.

Increased telomerase activity can be blocked by targeting the hTERT activity at both RNA and catalytic subunits. Various inhibitors had been used to regulate hTERT activity in glioblastoma cell lines and showed promising results. The present study hypothesized that the telomerase specific inhibitor BIBR1532 can effectively down-regulate the telomerase activity in LN18 glioblastoma cell line. LN18 glioblastoma cell line was treated with various concentrations of BIBR1532 at different time intervals. MTT assay was performed to determine cell viability after BIBR1532 treatment. hTERT mRNA and protein expression were determined by qRT-PCR and western blotting, respectively. Flow cytometry and TRAP assay was performed to detect the rate of apoptosis and telomerase activity in treated and control samples. One-way ANOVA was performed to compare the mean values of variables in control and BIBR1532 treated groups. LN18 cells showed a significant dose dependent cytotoxic effect after treatment with BIBR1532. hTERT mRNA expression in cells treated with 25, 100 and 200 µM BIBR1532 treated groups was decreased ~ 21, ~ 61.2, and ~ 77%, respectively (p < 0.05). We also observed that, BIBR1532 treatment reduced the expression of hTERT protein in LN18 cells in a dose dependent manner. The Flow cytometry data showed that, the drug induced significant increase in the total percentage of apoptotic cells with 200 µM concentration of BIBR1532 at all time points. BIBR1532 exhibited potent inhibition of telomerase activity in a dose-dependent manner in LN18 cells. BIBR1532 could induce apoptosis in LN18 cells through the downregulation of telomerase activity at transcriptional and translational level. We conclude that BIBR1532 may be a therapeutic agent to suppress telomerase activity, however, further efforts are necessary in order to explore this therapeutic strategy.

CD133 and BMI1 expressions and its prognostic role in primary glioblastoma.

Glioblastoma is the most common malignant brain tumour, generated by bulk of malignant cancer stem cells, which express various stem cell factors like CD133, BMI1 and nestin. There are several studies which show the importance of CD133 in cancer, but the function and interaction with other major oncogenes and tumour suppressor genes is still not understood. This study aimed to analyse the expression of CD133 mRNA and its correlations with BMI1 protein expression and TP53 mutations in newly diagnosed glioblastoma patients and its role in prognosis. Overexpression of CD133 mRNA and BMI1 protein was found in 47.6 and 76.2% patients respectively and TP53 mutations was seen in 57.1% of patients in our study.There was no correlation among TP53 mutations and expressions of CD133 and BMI1. We found that high level of BMI1 expression was favourable for the patient survival (P=0.0075) and high CD133 mRNA expression was unfavourable for the patient survival (P=0.0226).CD133 mRNA and BMI1 protein expression could independently predict the glioblastoma patient survival in multivariate analysis. In conclusion, the overexpression of these stem cell markers is a common event in glioblastoma progression and could be used as potential prognostic markers.